Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112043 · ClinicalTrials.gov registry record · Phase 1
Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial)
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 147
- Enrollment target
NCT04112043 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 147 participants.
The verdict
NCT04112043, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 147 participants
- Enrollment target
Study Summary
More than 80% of older adults have hypertension, with higher prevalence of high systolic blood pressure (SBP) putting them at high risk for cardiovascular (CV) disease and death. Novel compound, nicotinamide riboside may enhance the effects of exercise therapy in hypertensive older adults.
Interventions
- BEHAVIORAL Walking Exercise
- DRUG Nicotinamide Riboside (NR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2020-07-28 |
| Est. Completion | 2023-05-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04112043
The ClinicalTrials.gov registry entry for NCT04112043 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Walking Exercise is the first listed.
NCT04112043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04112043 about?
NCT04112043 is a clinical study titled "Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial)". More than 80% of older adults have hypertension, with higher prevalence of high systolic blood pressure (SBP) putting them at high risk for cardiovascular (CV) disease and death. Novel compound, nicotinamide riboside may enhance the effects of exercise therapy in hypertensive older adults.
What is the current status of trial NCT04112043?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 147 participants. The study started on 2020-07-28. Estimated completion is 2023-05-26.
What interventions are being tested in trial NCT04112043?
The interventions under investigation include: Walking Exercise (BEHAVIORAL), Nicotinamide Riboside (NR) (DRUG).
Who is sponsoring clinical trial NCT04112043?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.